Orgenesis Inc.
ORGS Healthcare Biotechnology
Orgenesis Inc.’s revenue for fiscal 2024 (year ended December 2024) was $1.0 million, up 95.3% from fiscal 2023. In the quarter to December 2024, revenue grew 82.4%, EPS fell 211.9% and free cash flow fell 317.9%, each against the same quarter a year earlier.
Follow ORGS
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Dec '24 | Sep '24 | Jun '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(49.01) | (35.26) | (29.72) | (51.55) |
+8 more TTM periods Free account |
Depreciation & Amortization |
2.09 | 1.82 | 1.47 | 1.36 | |
Non Cash Items (Other) |
28.19 | 15.01 | 11.67 | 11.90 | |
Accounts Receivable Change |
0.13 | (0.01) | (0.15) | 15.20 | |
Change in inventories |
0.03 | 0.03 | (0.34) | — | |
Accounts Payable Change |
(1.28) | (0.36) | 0.16 | 6.08 | |
Change in other assets and liabilities |
2.78 | 3.29 | 4.51 | 5.35 | |
Operating Cash Flow |
(17.08) | (15.48) | (12.03) | (12.04) | |
Capital expenditures |
(0.26) | (0.26) | (0.50) | (1.01) | |
Net Aquisitions |
0.14 | 0.14 | 0.14 | 0.14 | |
Long-Term Investments Change (Net) |
0.50 | 0.20 | 0.00 | (0.01) | |
Other investing activities |
(0.01) | 0.05 | 0.05 | (0.92) | |
Investing cash flow |
0.37 | 0.01 | (0.97) | (2.47) | |
Repayment/Issuance of Debt (Net) |
5.91 | 4.78 | 1.76 | 1.22 | |
Equity Repurchase (Common, Net) |
2.56 | 3.50 | 4.47 | 4.20 | |
Other financial activities |
7.49 | 7.51 | 6.72 | 5.91 | |
Financing cash flow |
15.96 | 15.79 | 12.95 | 11.32 | |
Exchange Rate Adjustment |
(0.04) | 0.02 | (0.01) | 0.02 | |
Change in Cash |
(0.79) | 0.33 | (0.07) | (3.17) | |
Beginning Cash |
1.48 | 1.48 | 1.48 | 1.48 | |
Ending Cash |
0.69 | 1.81 | 1.41 | (1.69) | |
Stock Based Compensation |
3.19 | 2.63 | 1.09 | 0.62 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
1.67 | 2.95 | 4.55 | 26.24 | |
Investments Change (Net) |
0.50 | 0.09 | (0.66) | (0.67) | |
Issuance/Purchase of Shares |
2.56 | 3.50 | 4.47 | 4.20 |